Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Thrombophilia and CYP2C9[original query] |
---|
CYP2C9 polymorphism studies in the Saudi population. Saudi medical journal 2011 Apr 32 (4): 347-52. Saour Jalal N, Shereen Atia W, Saour Basil J, Mammo Layla |
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Thrombosis research 2011 Jun 127 (6): 595-9. Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancacci |
Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers. Indian journal of human genetics 2012 Sep 18 (3): 326-31. Nahar Risha, Saxena Renu, Deb Roumi, Verma Ishwar |
The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population. Anatolian journal of cardiology 2016 Jan . Dilge Ta?k?n Birce, Kula Serdar, Ergün Mehmet Ali, Altun Demet, Olguntürk Rana, Tunao?lu Fatma Sedef, O?uz Ay?e Deniz, Gürsel Türk |
Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina. Croatian medical journal 2019 Jun 60 (3): 212-220. Ašic Adna, Salazar Ramona, Storm Niels, Dogan Serkan, Höppner Wolfgang, Marjanovic Damir, Primorac Drag |
Warfarin dose requirement in patients having severe thrombosis or thrombophilia. British journal of clinical pharmacology 2019 Apr . Helin Tuukka A, Joutsi-Korhonen Lotta, Asmundela Heidi, Niemi Mikko, Orpana Arto, Lassila Riit |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 18, 2024
- Content source: